Pharmaceutical

Johnson & Johnson gains FDA and EC approvals for TB treatment

Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (bedaquiline) to treat pulmonary tuberculosis (TB).

Jul 4, 2024 - 04:00
Johnson & Johnson gains FDA and EC approvals for TB treatment
Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (bedaquiline) to treat pulmonary tuberculosis (TB).
Read the original article

Tags:

Previous Article

Protecting your drug products: Strategies for preventing metal contamination in ...

Next Article

Moderna’s mRNA influenza vaccine receives $176m boost

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Former U.S. surgeons general: The U.S. should ban menthol cigarettes

Opinion: Former U.S. surgeons general: The U.S. should ...

Feb 9, 2024

Pan Cancer T raises funds through seed extension round

Pan Cancer T raises funds through seed extension round

Jul 14, 2024

STAT+: Sick patients collapsed waiting for care at Mass. hospital with known safety violations

STAT+: Sick patients collapsed waiting for care at Mass...

Feb 15, 2024